These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 17565006)
1. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006 [TBL] [Abstract][Full Text] [Related]
2. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis. Machida T; Heerdt PM; Reid AC; Schäfer U; Silver RB; Broekman MJ; Marcus AJ; Levi R J Pharmacol Exp Ther; 2005 May; 313(2):570-7. PubMed ID: 15647328 [TBL] [Abstract][Full Text] [Related]
3. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347 [TBL] [Abstract][Full Text] [Related]
4. Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia. Sesti C; Koyama M; Broekman MJ; Marcus AJ; Levi R J Pharmacol Exp Ther; 2003 Jul; 306(1):238-44. PubMed ID: 12676879 [TBL] [Abstract][Full Text] [Related]
5. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226 [TBL] [Abstract][Full Text] [Related]
6. The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons. Corti F; Olson KE; Marcus AJ; Levi R J Pharmacol Exp Ther; 2011 May; 337(2):524-32. PubMed ID: 21325440 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235 [TBL] [Abstract][Full Text] [Related]
8. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225 [TBL] [Abstract][Full Text] [Related]
9. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Mizumoto N; Kumamoto T; Robson SC; Sévigny J; Matsue H; Enjyoji K; Takashima A Nat Med; 2002 Apr; 8(4):358-65. PubMed ID: 11927941 [TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077 [TBL] [Abstract][Full Text] [Related]
12. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184 [TBL] [Abstract][Full Text] [Related]
13. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2. Alvarado-Castillo C; Harden TK; Boyer JL Mol Pharmacol; 2005 Jan; 67(1):114-22. PubMed ID: 15496502 [TBL] [Abstract][Full Text] [Related]
14. EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release. Sesti C; Broekman MJ; Drosopoulos JH; Islam N; Marcus AJ; Levi R J Pharmacol Exp Ther; 2002 Feb; 300(2):605-11. PubMed ID: 11805223 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases. Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867 [TBL] [Abstract][Full Text] [Related]
16. Decreased ecto-NTPDase1/CD39 activity leads to desensitization of P2 purinoceptors regulating tonus of corpora cavernosa in impotent men with endothelial dysfunction. Faria M; Magalhães-Cardoso T; Lafuente-de-Carvalho JM; Correia-de Sá P Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):761-8. PubMed ID: 18600538 [TBL] [Abstract][Full Text] [Related]
17. Extracellular ATP in activity-dependent remodeling of the neuromuscular junction. Jia M; Li MX; Fields RD; Nelson PG Dev Neurobiol; 2007 Jun; 67(7):924-32. PubMed ID: 17506503 [TBL] [Abstract][Full Text] [Related]
18. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase. Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057 [TBL] [Abstract][Full Text] [Related]